Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Aug 13 · below the Ichimoku cloud · RSI 44 · MACD above its signal · 5% above its 52-week low
None of the 29 investors followed here reported a position in 0241.HK in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a 0241.HK trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 16, 2026 | Sheng (Mengyue)Director (Executive) | Acquisition at price 0.42 per share. | 52K | $21.62K |
| Jun 14, 2026 | Shen (Difan)Chief Executive Officer | — | 517.5K | — |
| Dec 16, 2025 | Shen (Difan)Chief Executive Officer | Sale at price 0.67 per share. | 75 | $50 |
| Dec 16, 2025 | Tu (Yanwu)Chief Financial Officer | Sale at price 0.67 per share. | 75 | $50 |
| Dec 14, 2025 | Shen (Difan)Chief Executive Officer | — | 85K | — |
| Dec 14, 2025 | Tu (Yanwu)Chief Financial Officer | — | 56.7K | — |
| Jun 17, 2025 | Shen (Difan)Chief Executive Officer | Sale at price 0.58 per share. | 140K | $81.56K |
| Jun 17, 2025 | Tu (Yanwu)Chief Financial Officer | Sale at price 0.58 per share. | 62.7K | $36.52K |
| Jun 17, 2025 | Zhu (Shunyan)Chairman of the Board | Sale at price 0.58 per share. | 83.3K | $48.52K |
| Jun 14, 2025 | Shen (Difan)Chief Executive Officer | — | 466.1K | — |
| Jun 14, 2025 | Tu (Yanwu)Chief Financial Officer | — | 234.8K | — |
| Jun 14, 2025 | Zhu (Shunyan)Chairman of the Board | — | 322.3K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 28.9 | -14.4 | -16.5 | -6.2 | -16.9 | -15.2 | 16.6 | -13.9 | -7.3 | 0.3 | −43.2% | ||
| 2025 | 8.1 | 39.2 | -6.0 | 7.0 | -10.1 | 4.6 | 3.0 | 11.9 | 22.0 | -12.9 | -4.0 | -9.2 | +52.0% |
| 2024 | -32.5 | 20.3 | -7.6 | -6.9 | 10.8 | -4.6 | 5.8 | -9.1 | 77.7 | -26.5 | -7.1 | -8.8 | −21.5% |
| 2023 | 4.8 | -19.7 | 1.4 | -1.2 | -17.3 | 1.5 | 17.2 | -16.1 | 5.4 | -5.5 | -3.7 | -4.5 | −36.2% |
| 2022 | -11.5 | -6.7 | -6.6 | -10.4 | -12.1 | 35.0 | -12.6 | -3.6 | -20.9 | -7.8 | 92.5 | 4.1 | +0.9% |
| 2021 | 7.0 | 7.0 | -15.4 | 7.7 | -18.7 | -10.6 | -29.8 | 5.6 | -12.2 | -12.2 | -26.9 | -8.3 | −71.0% |
| 2020 | 21.8 | 36.3 | -13.3 | 44.8 | -3.2 | 24.4 | -5.3 | -12.5 | 0.9 | 7.3 | 12.6 | -0.4 | +152.2% |
| 2019 | 13.1 | 12.1 | 12.7 | 3.4 | -20.8 | 0.7 | -4.9 | 4.5 | -7.8 | 15.5 | 12.0 | 1.6 | +41.7% |
| 2018 | 3.5 | -5.9 | 1.3 | 1.8 | 81.1 | 5.3 | 6.2 | -1.2 | -3.4 | -17.3 | 10.4 | -9.3 | +60.8% |
| 2017 | -7.4 | -5.5 | 2.6 | -13.4 | 31.0 | -6.3 | 0.0 | -1.9 | 6.8 | 7.2 | -7.9 | 2.6 | +1.3% |
| 2016 | -27.4 | 5.9 | 14.8 | 11.0 | 8.0 | 0.2 | -5.1 | -10.4 | -10.1 | -6.5 | 6.9 | -10.1 | −27.2% |
| 2015 | 0.6 | 3.5 | 27.9 | 77.0 | -10.7 | -24.8 | -10.8 | -25.5 | -7.8 | 25.5 | -4.4 | -9.6 | +5.3% |
| 2014 | 555.4 | 15.0 | 35.1 | -24.4 | 43.6 | -2.7 | -1.3 | 2.7 | -22.6 | 2.5 | 12.8 | -6.8 | +808.9% |
| 2013 | 22.2 | -7.3 | -9.8 | -6.5 | 18.6 | -20.6 | 2.5 | -1.2 | -2.4 | 20.0 | 10.4 | 5.7 | +24.4% |
| 2012 | 1.2 | 37.9 | -20.0 | -8.3 | -10.2 | -3.8 | -5.3 | 11.1 | -1.2 | 21.5 | -2.1 | -4.3 | +4.7% |
| 2011 | -6.3 | -12.4 | 43.6 | -8.9 | -2.9 | -13.1 | -1.2 | -18.8 | -21.7 | 18.5 | -10.9 | -24.6 | −54.7% |
| 2010 | 69.9 | 1.4 | 22.4 | -2.9 | -22.9 | -20.6 | 0.0 | 17.3 | 3.3 | -7.9 | -16.4 | -2.1 | +14.5% |
| 2009 | -13.3 | 0.0 | 6.2 | 11.6 | 114.3 | -22.7 | 15.7 | -22.0 | -3.9 | 6.3 | 125.5 | 56.6 | +453.3% |
| 2008 | -11.8 | 11.7 | -22.4 | 1.9 | -3.8 | -10.8 | -28.6 | -25.5 | -29.3 | -29.8 | 18.3 | 5.6 | −77.9% |
| 2007 | -7.8 | 4.8 | 3.4 | 5.6 | 68.4 | -25.0 | -10.8 | -7.5 | -14.1 | -7.1 | -21.5 | 9.7 | −24.4% |
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in the People's Republic of China. It offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. The company also provides medical and healthcare services, including medical checkups, testing, medical consultation, appointment-booking, physical examination, consultation, registration, vaccine, dentistry, psychology, optometry, and nursing services, as well as traditional chinese medicines. In addition, it engages in the digital tracking business; asset management; and operation of internet hospitals, as well as provision of network hospital, research, and Internet information services. Further, the company operates Alibaba Health, flagship platform of Alibaba Group for integrated online and offline medical and healthcare resources, providing one-stop healthcare solutions. It provides products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Taobao Instant Commerce, AMap, DingTalk, Freshippo, and Quark. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.
Buy / hold / sell counts
No recent headlines.